Nitric oxide and the brain

International Anesthesiology Clinics

Volumn 34, Issue 4, 1996, Pages 113-132

  Pelligrino, Dale A ^a   Baughman, Verna L ^a   Koenig, Heidi M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANTICONVULSANT ACTIVITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; DRUG POTENTIATION; HUMAN; HYPERCAPNIA; HYPOXIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; NEUROTOXICITY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; VASODILATATION;

EID: 0029838021     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199603440-00009     Document Type: Review

References (106)

1. Butler AR, Flitney FW, Williams DLH. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol Sci 1995;16:18-22
2. Bolotina VM, Najibi S, Palacino JJ, et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368: 850-853
3. Pelligrino DA. Saying NO to cerebral ischemia. J Neurosurg Anesth 1993;5: 221-231
4. Lipton SA, Choi YB, Pan ZH, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993;364:626-632
5. Wood PL. Nitric oxide and excitatory amino acid-coupled signal transduction in the cerebellum and hippocampus. In: Nitric oxide in the nervous system. London: Academic Press, 1995:103-123
6. Forstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmied Arch Pharmacol 1995;352: 351-364
7. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994;14: 175-192
8. Hibbs JB. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res Immunol 1991;142:565-569
9. Varner PD, Beckman JS. Nitric oxide toxicity in neuronal injury and degeneration. In: Nitric oxide in the nervous system. New York: Academic Press, 1995:191-206
10. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051-3064
11. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142
12. Archer S. Measurement of nitric oxide in biological models, FASEB J 1993;7: 349-360
13. Moore PK, Wallace P, Gaffen Z, et al. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles - antinociceptive and cardiovascular effects. Br J Pharmacol 1993;110:219-224
14. Wang Q, Pelligrino DA, Baughman VL, et al. The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb Blood Flow Metab 1995;15:774-778
15. Yoshida T, Limmroth V, Irikura K, et al. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 1994;14:924-929
16. Iadecola C, Zhang FY, Xu XH. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 1995;37:R286-R292
17. Malinski T, Bailey F, Zhang ZG, et al. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 1993;13:355-358
18. Dawson DA. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 1994;6:299-324
19. Buisson A, Plotkine M, Boulu RG. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br J Pharmacol 1992;106: 766-767
20. Nagafuji T, Matsui T, Koide T, et al. Blockade of nitric oxide formation by N omega-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci Lett 1992;147:159-162
21. Nowicki JP, Duval D, Poignet H, et al. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 1991;204:339-340
22. Kuluz JW, Prado RJ, Dietrich WD, et al. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 1993;24:2023-2029
23. Ashwal S, Cole DJ, Osborne TN, et al. Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model. J Neurosurg Anesth 1993;5:241-249
24. Ashwal S, Cole DJ, Osborne TN, et al. Dual effects of 1-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats. Am J Physiol 1994; 267:H276-H284
25. Feuerstein G, Liu T, Clark R, et al. Inflammatory reaction in brain ischemia - the role of leukocytes and interleukin-1β. J Cereb Blood Flow Metab 1993;13 (Suppl 1):S26
26. Lees GJ. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 1993;114:119-122
27. Iadecola C, Xu XH, Zhang FY, et al. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab 1995;15:52-59
28. Iadecola C, Zhang FG, Xu S, et al. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 1995;15: 378-384
29. Zhang ZG, Chopp M, Zaloga C, et al. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 1993;24:2016-2021
30. Zhang ZG, Chopp M, Gautam S, et al. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res 1994;654:85-95
31. Huang ZH, Huang PL, Panahian N, et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994;265:1883-1885
32. Hoffman WE, Braucher E, Pelligrino DA, et al. Brain lactate and neurologic outcome following incomplete ischemia in fasted, nonfasted, and glucose-loaded rats. Anesthesiology 1990;72:1045-1050
33. Huang Z, Huang PL, Fishman MC, et al. Focal cerebral ischemia in mice deficient in either endothelial (eNOS) or neuronal nitric oxide (nNOS) synthase. Stroke 1996;27:173
34. Lee HC. A signaling pathway involving cyclic ADP-ribose, cGMP, and nitric oxide. News Physiol Sci 1994;9:134-137
35. Zhang J, Dawson VL, Dawson TM, et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994;263:687-689
36. Lonart G, Wang J, Johnson KM. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 1992;220:271-272
37. Siesjo BK, Memezawa H, Smith ML. Neurocytotoxicity: pharmacological implications. Fundam Clin Pharmacol 1991;5:755-767
38. Lonart G, Cassels KL, Johnson KM. Nitric oxide induces calcium-dependent [h-3]-dopamine release from striatal slices. J Neurosci Res 1993;35:192-198
39. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol 1990;47:1245-1254
40. Chan PH, Kamii H, Yang G, et al. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. NeuroReport 1993;5: 293-296
41. Yang GY, Chan PH, Chen J, et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994;25:165-170
42. Shiga Y, Onodera H, Kogure K, et al. Effect of depletion of neutrophils on infarct size following transient focal brain ischemia. J Cereb Blood Flow Metab 1993; 13(Suppl 1):S117
43. Shiga Y, Onodera H, Matsuo Y, et al. Cyclosporin A protects against ischemia-reperfusion injury in the brain. J Cereb Blood Flow Metab 1993;13(Suppl 1):S118
44. Sato S, Tominaga T, Ohnishi T, et al. EPR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochem Biophys Acta 1993;1181:195-197
45. Caldwell M, Oneill M, Earley B, et al. N-g-nitro-1-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil. Eur J Pharmacol 1994;260:191-200
46. Nagafuji T, Sugiyama M, Matsui T, et al. A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury. Eur J Pharmacol 1993;248:325-328
47. Moncada C, Lekieffre D, Arvin B, et al. Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions. NeuroReport 1992;3: 530-532
48. Sancesario G, Iannone M, DAngelo V, et al. N omega-nitro-L-arginine-methyl ester inhibits electrocortical recovery subsequent to transient global brain ischemia in Mongolian gerbil. Funct Neurol 1992;7:123-127
49. Weissman BA, Kadar T, Brandeis R, et al. NG-nitro-L-arginine enhances neuronal death following transient forebrain ischemia in gerbils. Neurosci Lett 1992;146: 139-142
50. Buchan AM, Gertler SZ, Huang ZG, et al. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase. Neuroscience 1994;61:1-11
51. Shapira S, Kadar T, Weissman BA. Dose-dependent effect of nitric oxide synthase inhibition following transient forebrain ischemia in gerbils. Brain Res 1994;668: 80-84
52. Manzoni O, Prezeau L, Marin P, et al. Nitric oxide-induced blockade of NMDA receptors. Neuron 1992;8:653-662
53. Rubbo H, Radi R, Trujillo M, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation-formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994;269:26066-26075
54. Wink DA, Gook JA, Krishna MC, et al. Nitric oxide protects against alkyl peroxide-mediated cytotoxicity: further insights into the role nitric oxide plays in oxidative stress. Arch Biochem Biophys 1995;319:402-407
55. Fukahori M, Ichimori K, Ishida H, et al. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radical Res 1994;21:203-212
56. Cole DJ, Drummond JC, Osborne TN, et al. Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema. Am J Physiol 1990;259: H211-H217
57. Kindy MS, Hu YG, Dempsey RJ. Blockade of ornithine decarboxylase enzyme protects against ischemic brain damage. J Cereb Blood Flow Metab 1994;14: 1040-1045
58. Otsuki M, Davidson M, Goodenough S, et al. In vivo pharmacological study of spermine-induced neurotoxicity. Neurosci Lett 1995;196:81-84
59. Dawson VL. Nitric oxide: role in neurotoxicity. Clin Exp Pharmacol Physiol 1995; 22:305-308
60. Schoedon G, Schneemann M, Hofer S, et al. Regulation of the 1-arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur J Biochem 1993;213:833-839
61. Chumas PD, Del Bigio MR, Drake JM, et al. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia. J Neurosurg 1993;79:414-420
62. Shimauchi M, Yamamoto YL. Effects of retrograde perfusion of the brain with combined drug therapy after focal ischemia in rat brain. Stroke 1992;23: 1805-1810
63. Theard MA, Baughman VL, Wang Q, et al. The role of nitric oxide in modulating brain activity and blood flow during seizure. NeuroReport 1995;6:921-924
64. Pelligrino DA, Gay RL, Baughman VL, et al. Nitric oxide synthase inhibition modulates N-methyl-D-aspartate-induced changes in cerebral blood flow and EEG activity. Am J Physiol 1996 (in press)
65. Buisson A, Lakhmeche N, Verrecchia C, et al. Nitric oxide: an endogenous anticonvulsant substance. NeuroReport 1993;4:444-446
66. Rondouin G, Bockaert J, Lernernatoli M. L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport 1993;4: 1187-1190
67. Wang Q, Theard A, Pelligrino DA, et al. Nitric oxide as an endogenous anticonvulsant but not a mediator of the cerebral hyperemia accompanying bicuculline treatment in rats. Brain Res 1994;658:192-198
68. Fagni L, Olivier M, Lafoncazal M, et al. Involvement of divalent ions in the nitric oxide-induced blockade of n-methyl-d-aspartate receptors in cerebellar granule cells. Mol Pharmacol 1995;47:1239-1247
69. Kamisaki Y, Wada K, Nakamoto K, et al. Nitric oxide inhibition of the depolarization-evoked glutamate release from synaptosomes of rat cerebellum. Neurosci Lett 1995;194:5-8
70. Rundfeldt C, Koch R, Richter A, et al. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol 1995;274:73-81
71. Macrae IM, Dawson DA, Norrie JD, et al. Inhibition of nitric oxide synthesis - effects on cerebral blood flow and glucose utilisation in the rat. J Cereb Blood Flow Metab 1993;13:985-992
72. Bryan RM, Steenberg ML, Eichler MY, et al. Permissive role of NO in alpha(2)-adrenoceptor-mediated dilations in rat cerebral arteries (rapid communication). Am J Physiol 1995;38:H1171-H1174
73. Iadecola C, Zhang FY, Xu XH. SIN-1 reverses attenuation of hypercapnic cerebrovasodilation by nitric oxide synthase inhibitors. Am J Physiol 1994;267: R228-R235
74. Dreier JP, Korner K, Corner A, et al. Nitric oxide modulates the CBF response to increased extracellular potassium. J Cereb Blood Flow Metab 1995;15:914-919
75. Iadecola C, Zhang F. Nitric oxide-dependent and independent components of cerebrovasodilation elicited by hypercapnia. Am J Physiol 1994;266:R546-R552
76. G-nitro-L-arginine and indomethacin on the hypercapnic cerebral blood flow increase in rats. Brain Res 1994;641:257-264
77. Eckly AE, Lugnier C. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br J Pharmacol 1994;113:445-450
78. Wagerle LC, Degiulio PA. Indomethacin-sensitive CO2 reactivity of cerebral arterioles is restored by vasodilator prostaglandin. Am J Physiol 1994;266:H1332-H1338
79. Wang Q, Pelligrino DA, Koenig HM, Albrecht RF. The role of endothelium and nitric oxide in rat pial arteriolar dilatory responses to CO2 in vivo. J Cereb Blood Flow Metab 1994;14:944-951
80. Irikura K, Huang PL, Ma JY, et al. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci USA 1995;92: 6823-6827
81. Devasconcelos AP, Baldwin RA, Wasterlain CG. Nitric oxide mediates the increase in local cerebral blood flow during focal seizures. Proc Natl Acad Sci USA 1995; 92:3175-3179
82. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 1993;72:476-480
83. Wang Q, Kjaer T, Jorgensen MB, et al. Nitric oxide does not act as a mediator coupling cerebral blood flow to neural activity following somatosensory stimuli in rats. Neurol Res 1993;15:33-36
84. Dirnagl U, Niwa K, Lindauer U, et al. Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am J Physiol 1994;267:H296-H301
85. Irikura K, Maynard KI, Moskowitz MA. Importance of nitric oxide synthase inhibition to the attenuated vascular responses induced by topical L-nitroarginine during vibrissal stimulation. J Cereb Blood Flow Metab 1994;14:45-48
86. Ma J, Ayata C, Meng W, et al. Regional CBF response to vibrissal stimulation in mice lacking neuronal or endothelial NOS gene expression. Soc Neurosci Abstr 1995;21:434
87. Pelligrino DA, Wang Q, Koenig HM, Albrecht RF. Role of nitric oxide, adenosine, N-methyl-D-aspartate receptors, and neuronal activation in hypoxia-induced pial arteriolar dilation in rats. Brain Res 1995;704:61-70
88. Meller ST, Lewis SJ, Bates JN, et al. Is there a role for an endothelium-derived relaxing factor in nociception? Brain Res 1990;531:342-345
89. Semos ML, Headley PM. The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology 1994;33:1487-1497
90. Przewlocki R, Machelska H, Przewlocka B. Modulation of morphine and cocaine effects by inhibition of nitric oxide synthase. Regul Pept 1994;54:233-235
91. Meller ST, Cummings CP, Traub RJ, et al. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994;60:367-374
92. Iwamoto ET, Marion L. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an 1-arginine/nitrk oxide/cyclic GMP cascade in rats. J Pharmacol Exp Ther 1994;271:601-608
93. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991;102:198-202
94. Kawabata A, Umeda N, Takagi H. L-arginine exerts a dual role in nociceptive processing in the brain - involvement of the kyotorphin-met-enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol 1993;109:73-79
95. Kumar A, Raghubir R, Srimal RC, et al. Evidence for involvement of nitric oxide in pretectal analgesia in rat. NeuroReport 1993;4:706-708
96. Ji XQ, Zhu XZ. Possible involvement of nitric oxide in arginine-induced analgesia. Acta Pharmacol Sin 1993;14:289-291
97. Xu JY, Tseng LF. Increase of nitric oxide by L-arginine potentiates beta-endorphin- but not mu-, delta- or kappa-opioid agonist-induced antinociception in the mouse. Eur J Pharmacol 1993;236:137-142
98. Hara S, Kuhns ER, Ellenberger EA, et al. Involvement of nitric oxide in intracerebroventricular beta-endorphin-induced neuronal release of methionine-enkephalin. Brain Res 1995;675:190-194
99. Kumar A, Raghubir R, Dhawan BN. Possible involvement of nitric oxide in red nucleus stimulation-induced analgesia in the rat. Eur J Pharmacol 1995;279:1-5
100. Przewocki R, Machelska H, Przewocka B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci 1993;53:PL1-PL5
101. Brignola G, Calignano A, Dirosa M. Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 1994;113:1372-1376
102. Johns RA, Moscicki JC, DiFazio CA. Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. Anesthesiology 1992;77:779-784
103. Ichinose F, Huang PL, Zapol WM. Effects of targeted neuronal nitric oxide synthase gene disruption and nitro(g)-1-arginine methylester on threshold for isoflurane anesthesia. Anesthesiology 1995;83:101-108
104. Johns RA. Nitric oxide and minimum alveolar concentration: TKO or knockout? Anesthesiology 1995;83:6-7
105. Crosby G, Marota JJA, Huang PL. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 1995; 69:1013-1017
106. Schuman EM, Madison DV. Nitric oxide and synaptic function. Ann Rev Neurosci 1994;17:153-183